학술논문
The absence of a novel intron 19-retaining ALK transcript (ALK-I19) and MYCN amplification correlates with an excellent clinical outcome in neuroblastoma patients
Document Type
Article
Author
Source
In: Oncotarget . (Oncotarget, 2018, 9(12):10698-10713)
Subject
Language
English
ISSN
19492553